[Form 4] Core Scientific, Inc. Tranche 2 Warrants Insider Trading Activity

Rhea-AI Filing Summary

Todd DuChene, Chief Legal and Administrative Officer of Core Scientific, Inc. (CORZ), reported a Form 4 disclosing a transaction dated 08/15/2025. The filing shows 11,805 shares of Common Stock were disposed under transaction code F(1) at a price of $14.13 per share; the filing explains these shares were withheld to satisfy tax withholding upon vesting of restricted stock units. Following the withholding, Mr. DuChene beneficially owns 2,029,656 shares, held directly. The Form 4 is signed and dated 08/19/2025 by the reporting person.

Insights

Securities Analyst

TL;DR: Routine tax-withholding on RSU vesting; no new purchases or sales beyond shares withheld.

The Form 4 reports a common, administrative disposition: 11,805 shares were withheld at $14.13 to cover taxes on vested restricted stock units. This transaction is recorded under code F(1), consistent with withholding rather than an active open-market sale. Beneficial ownership after the transaction is 2,029,656 shares, held directly by the officer. From a disclosure perspective this is standard insider reporting and carries neutral immediate market implication.

Corporate Governance Expert

TL;DR: Administrative RSU tax withholding disclosed; no governance or control change indicated.

The filing identifies the reporting person as an officer (Chief Legal and Administrative Officer) and records withholding to satisfy tax obligations upon RSU vesting. The nature of the transaction is explicitly described in the remarks as tax withholding, and the Form 4 shows direct ownership remaining at 2,029,656 shares. There is no indication of additional derivative activity, 10% owner status, or changes in voting/control in this disclosure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DUCHENE TODD M

(Last) (First) (Middle)

C/O CORE SCIENTIFIC, INC.

838 WALKER ROAD, SUITE 21-2105

(Street)

DOVER DE 19904

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Core Scientific, Inc./tx [ CORZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See remarks

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		F(1)		11,805	D	$14.13	2,029,656	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.

Remarks:

Chief Legal and Administrative Officer

	/s/ Todd DuChene	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Core Scientific insider Todd DuChene report on Form 4 (CORZ)?

The Form 4 reports that 11,805 shares were withheld to satisfy tax withholding upon the vesting of restricted stock units, recorded as transaction code F(1) on 08/15/2025.

How many Core Scientific (CORZ) shares does Todd DuChene beneficially own after the reported transaction?

Following the reported withholding, the filing shows Mr. DuChene beneficially owns 2,029,656 shares, held directly.

At what price were the shares withheld in the CORZ Form 4 filing?

The withheld shares are reported at a price of $14.13 per share.

When was the Form 4 transaction for Core Scientific filed and signed?

The transaction date is 08/15/2025; the Form 4 is signed by Todd DuChene and dated 08/19/2025.

What is the stated reason for the share disposition in the Form 4 for CORZ?

The filing explains the shares were withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.